Back to Directory

Theodore Ruel

Email

Institution

University of California San Francisco

Address

University of California San Francisco
Division of Pediatric Infectious Diseases and Global Health, Department of Pediatrics
550 16th Street, Box 0434
San Francisco, CA 94158

Request an Update

Affiliated Studies

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Pharmacokinetics, and antiviral activity of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed HIV-Infected Children >2 to <12 years of age and weighing >10 kgs and <50 kgs

Research Area

Treatment

Study Status

In Development

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

38693

Research Area

Cure

Study Status

Pending

P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure

Study Status

Enrolling

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Treatment

Study Status

Closed to Accrual